News

The European Commission has delivered a hefty fine to Teva for abusing a dominant position in multiple sclerosis by artificially extending the patent protection for former blockbuster Copaxone.
We use cookies and similar technologies to provide our services and to measure and improve your experience. If you choose ‘Accept’, the online marketing you see about ITV will be more relevant ...